Phase 1 ALKS 1140 in Healthy Adults

NCT05019105 · clinicaltrials.gov ↗

PHASE1

Phase

TERMINATED

Status

20

Enrollment

INDUSTRY

Sponsor class

Stopped Sponsor Decision

Conditions

Central Nervous System Diseases

Interventions

DRUG: Placebo
DRUG: ALKS 1140

Sponsor

Alkermes, Inc.